Overview
- Istat’s competitiveness report, published Monday, found about 60% of Italy’s 2025 strategic imports came from countries with medium or high political risk.
- China’s share reached 10.3% of total imports, with Istat noting a roughly 60% rise since 2017 in Chinese intermediate inputs used by Italian factories.
- Pharmaceutical purchases from China jumped from €680 million in 2024 to more than €7.7 billion in 2025, alongside strong gains in vehicles and other transport goods.
- Most exporters to the United States saw little direct disruption from new tariffs, yet Istat estimates a tariff doubling corresponded to 3.2% lower export growth in 2025.
- Sales to the United States still grew 7.2% in 2025, but Istat’s simulation shows a full stop would shave about 1.1% from GDP or roughly €20 billion.